Supramolecular PEGylation of biopharmaceuticals
The covalent modification of therapeutic biomolecules has been broadly explored, leading to a number of clinically approved modified protein drugs. These modifications are typically intended to address challenges arising in biopharmaceutical practice by promoting improved stability and shelf life of...
| Main Authors: | , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
National Academy of Sciences (U.S.)
2017
|
| Online Access: | http://hdl.handle.net/1721.1/111202 https://orcid.org/0000-0003-0624-3532 https://orcid.org/0000-0002-2301-7126 https://orcid.org/0000-0002-8227-953X https://orcid.org/0000-0003-4255-0492 https://orcid.org/0000-0001-5629-4798 |